429 Kent Street unit 112 Ottawa, ON K2P 2B4 Canada 613-241-9959 http://www.cttpharmaceuticals.com
Excerpts from PR on April 16, 2018 http://www.cttpharmaceuticals.com/aurora-cannabis-gains-exclusive-license-to-novel-patented-sub-lingual-wafer-technology-from-ctt-pharmaceutical/ Dr. Pankaj Modi, CEO of CTT Pharma, added, “We are excited about the growth potential that our exclusive Canadian partnership with CanniMed and Aurora offers. Their large and rapidly growing patient base, both in Canada and around the world represent a significant distribution opportunity for our sub-lingual wafer technology, and with the establishment of CanniMed as the heart of Aurora’s Medical Cannabis Centre of Excellence, we anticipate that Aurora’s proven track record of execution will accelerate market development for our products.”
The following list details all of CTT’s patents, their filing dates, and issuance dates:
Canadian Patents
US Patents
World Patents